A review of design criteria for cancer-targeted, nanoparticle-based MRI contrast agents

This publication has 230 references indexed in Scilit:

• Metal‐Based Nanoparticle Magnetic Resonance Imaging Contrast Agents: Classifications, Issues, and Countermeasures toward their Clinical Translation
  Advanced Materials Interfaces, 2022
• Stimulus‐Responsive Nanoparticle Magnetic Resonance Imaging Contrast Agents: Design Considerations and Applications
  Advanced Healthcare Materials, 2020
• Sulfoxide‐Containing Polymer‐Coated Nanoparticles Demonstrate Minimal Protein Fouling and Improved Blood Circulation
  Advanced Science, 2020
• A Nanostrategy for Efficient Imaging‐Guided Antitumor Therapy through a Stimuli‐Responsive Branched Polymeric Prodrug
  Advanced Science, 2020
• Manganese‐Based Functional Nanoplatforms: Nanosynthetic Construction, Physiochemical Property, and Theranostic Applicability
  Advanced Functional Materials, 2019
• MUC‐1 aptamer targeted superparamagnetic iron oxide nanoparticles for magnetic resonance imaging of pancreatic cancer in vivo and in vitro experiment
  Journal of Cellular Biochemistry, 2019
• Recent Progress on Manganese‐Based Nanostructures as Responsive MRI Contrast Agents
  Chemistry – A European Journal, 2018
• Toxicity of iron oxide nanoparticles: Size and coating effects
  Journal of Biochemical and Molecular Toxicology, 2018
• Anchoring Group Effects of Surface Ligands on Magnetic Properties of Fe₃O₄ Nanoparticles: Towards High Performance MRI Contrast Agents
  Advanced Materials, 2014
• Transverse relaxation of solvent protons induced by magnetized spheres: Application to ferritin, erythrocytes, and magnetite
  Magnetic Resonance in Medicine, 1987